Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen

Physical Therapy

Volumn 77, Issue 7, 1997, Pages 751-764

  Almeida, Gil L ^a   Campbell, Suzann K ^a   Girolami, Gay L ^a   Penn, Richard D ^a   Corcos, Daniel M ^a  

^a NONE

Author keywords

Baclofen; Cerebral palsy; Drug therapy; Motor activity; Pediatrics; Treatment

Indexed keywords

BACLOFEN;

ARTICLE; BABINSKI REFLEX; CASE REPORT; CEREBRAL PALSY; CHILD; CLONUS; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; MUSCLE STRENGTH; SPASTICITY; VOLUNTARY MOVEMENT;

EID: 0030747272     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.1093/ptj/77.7.751     Document Type: Article

References (32)

1. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Miami, Fla: Symposia Specialists; 1980:485-500.
2. Camphell SK, Almeida GL, Penn RD, Corcos DM. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther. 1995;75:352-362.
3. Landau WM. Spasticity: the fable of a neurological demon and the emperor's new therapy. Arch Neurol. 1974;31:217-219.
4. Sahrmann SA, Norton BJ. The relationship of voluntary movement to spasticity in the upper motor neuron syndrome. Ann Neurol. 1977;2:460-465.
5. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236-240.
6. Penn RD, Corcos DM. Management of spasticity by central nervous system infusion techniques. In: Youmans JR, ed. Youmans Neurological Surgery, Volume 5. 4th ed. Philadelphia, Pa: WB Saunders Co; 1996: 3687-3700.
7. Corcos DM, Gottlieb GL, Penn RD, et al. Movement deficits caused by hyperexcitable stretch reflexes in spastic humans. Brain. 1986;109; 1043-1058.
8. Latash ML, Penn RD, Corcos DM, Gottlieb GL. Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg. 1990;72:388-392.
9. Albright AL, Ceervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA. 1991;265:1418-1422.
10. Albright AL, Barron WB, Fasick MP, et al. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA. 1993;270: 2475-2477.
11. Armstrong RW, Steinbok P, Farrell K, et al. Continuous intrathecal baclofen treatment of severe spasms in two children with spinal-cord injury. Dev Med Child Neurol. 1992;34:731-738.
12. Ashworth B. Preliminary trial of carisoprolol in multiple sclerosis. Practitioner. 1964;192:540-542.
13. National Institutes of Health. Research Plan for the National Center for Medical Rehabilitation Research. Washington, DC: US Dept of Health and Human Services; March 1993. NIH Publication No. 93-3509.
14. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320:1517-1521.
15. Latash ML, Penn RD, Corcos DM, Gottlieb GL. Short-term effects of intrathecal baclofen in spasticity. Exp Neurol. 1989;103;165-172.
16. Almeida GL, Hong D, Corcos DM, Gottlieb GL. Organizing principles for voluntary movement: extending single joint rules. J Neurophysiol. 1995;74:1374-1381.
17. Gottlieb GL, Corcos DM, Agarwal GC. Organizing principles for single joint movements, I: a speed-insensitive strategy. J Neurophysiol. 1989;62:342-357.
18. Almeida GL, Corcos DM, Latash ML. Practice and transfer effects during fast single-joint elbow movements in individuals with Down syndrome. Phys Ther. 1994;74:1000-1016.
19. Harris SR, Smith LH, Krukowski L. Goniometric reliability for a child with spastic quadriplegia. J Pediatr Orthop. 1985;5:348-351.
20. Stuberg WA, Fuchs RH, Miedaner JA. Reliability of goniometric measurements of children with cerebral palsy. Dev Med Child Neurol. 1988;30:657-666.
21. O'Dwyer N, Neilson P, Nash J. Reduction of spasticity in cerebral palsy using feedback of the tonic stretch reflex: a controlled study. Dev Med Child Neurol. 1994;36:770-786.
22. Russell D, Rosenbaum P, Gowland C, et al. Gross Motor Function Measure Manual. 2nd ed. Hamilton, Ontario, Canada: McMaster University; 1993.
23. Leonard CT, Hirschfeld H. Myotatic reflex responses of non-disabled children and children with spastic cerebral palsy. Dev Med Child Neurol. 1995;37:783-799.
24. Kroin JS, Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery. 1993;33:226-230.
25. Lundberg A. Longitudinal study of physical working capacity of young people with spastic cerebral palsy. Dev Med Child Neurol. 1984; 26:328-334.
26. Parker DF, Carriere L, Hebestreit H, et al. Muscle performance and gross motor function of children with spastic cerebral palsy. Dev Med Child Neurol. 1993;35:17-23.
27. Haley SM, Coster WJ, Ludlow LH, et al. The Pediatric Evaluation of Disability Inventory: Development Standardization and Administration Manual. Boston, Mass: New England Medical Center Publications; 1992.
28. Law M, Baptiste S, McColl MA, et al. The Canadian Occupational Performance Measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990;57:82-87.
29. McLaughlin JF, Bjornson KF, Astley SJ, et al. The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series. Dev Med Child Neurol. 1994;36:755-769.
30. Abott R. Complications with selective posterior rhizotomy. Pediatr Neurosurg. 1992;18:43-47.
31. Greene WB, Dietz FR, Goldberg MJ, et al. Rapid progression of hip subluxation in cerebral palsy after selective posterior rhizotomy. J Pediatr Orthop. 1991;11:494-497.
32. Crenna P, Inverno M, Frigo C, et al. Pathophysiological profile of gait in children with cerebral palsy. In: Forssberg H, Hirschfeld H, eds. Movement Disorders in Children. Basel, Switzerland: S Karger AG, Medical and Scientific Publishers; 1992:186-198.